Late-life restoration of mitochondrial function reverses cardiac dysfunction in old mice

  1. Ying Ann Chiao  Is a corresponding author
  2. Huiliang Zhang
  3. Mariya Sweetwyne
  4. Jeremy Whitson
  5. Ying Sonia Ting
  6. Nathan Basisty
  7. Lindsay K Pino
  8. Ellen Quarles
  9. Ngoc-Han Nguyen
  10. Matthew D Campbell
  11. Tong Zhang
  12. Matthew J Gaffrey
  13. Gennifer Merrihew
  14. Lu Wang
  15. Yongping Yue
  16. Dongsheng Duan
  17. Henk L Granzier
  18. Hazel H Szeto
  19. Wei-Jun Qian
  20. David Marcinek
  21. Michael J MacCoss
  22. Peter Rabinovitch  Is a corresponding author
  1. Oklahoma Medical Research Foundation, United States
  2. University of Washington, United States
  3. Buck Institute for Research on Aging, United States
  4. Pacific Northwest National Laboratory, United States
  5. University of Missouri, United States
  6. University of Arizona, United States
  7. Social Profit Network, United States

Abstract

Diastolic dysfunction is a prominent feature of cardiac aging in both mice and humans. We show here that 8-week treatment of old mice with the mitochondrial targeted peptide SS-31 (elamipretide) can substantially reverse this deficit. SS-31 normalized the increase in proton leak and reduced mitochondrial ROS in cardiomyocytes from old mice, accompanied by reduced protein oxidation and a shift towards a more reduced protein thiol redox state in old hearts. Improved diastolic function was concordant with increased phosphorylation of cMyBP-C Ser282 but was independent of titin isoform shift. Late-life viral expression of mitochondrial-targeted catalase (mCAT) produced similar functional benefits in old mice and SS-31 did not improve cardiac function of old mCAT mice, implicating normalizing mitochondrial oxidative stress as an overlapping mechanism. These results demonstrate that pre-existing cardiac aging phenotypes can be reversed by targeting mitochondrial dysfunction and implicate mitochondrial energetics and redox signaling as therapeutic targets for cardiac aging.

Data availability

Data file for metabolomic analysis (Table S1) and statistics of all proteins identified by proteomic analysis (Table S3) have been provided as supplementary materials.The raw mass spec files for proteomics analysis of S-glutathionylation were uploaded to MassIVE and can be accessed via the following link ftp://massive.ucsd.edu/MSV000085329/The raw mass spectrometry files for global proteomic analysis were uploaded to MassIVE and can be accessed via the following link ftp://massive.ucsd.edu/MSV000084961/The image files for ROS (Fig 2a and b) and senescence (Fig 4b and c) analyses can be accessed via the following link and were also included as supporting zip documents. https://www.dropbox.com/sh/0r50ew6xnpunc3t/AAA_HbJ0fQwhOUpDbI9Oq07va?dl=0

Article and author information

Author details

  1. Ying Ann Chiao

    Aging and Metabolism Research Program, Oklahoma Medical Research Foundation, OKlahom City, United States
    For correspondence
    Ann-Chiao@omrf.org
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-1256-4335
  2. Huiliang Zhang

    Pathology, University of Washington, Seattle, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Mariya Sweetwyne

    Pathology, University of Washington, Seattle, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Jeremy Whitson

    Pathology, University of Washington, Seattle, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Ying Sonia Ting

    Genome Science, University of Washington, Seattle, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Nathan Basisty

    Buck Institute for Research on Aging, Novato, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Lindsay K Pino

    Genome Science, University of Washington, Seattle, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. Ellen Quarles

    Pathology, University of Washington, Seattle, United States
    Competing interests
    The authors declare that no competing interests exist.
  9. Ngoc-Han Nguyen

    Pathology, University of Washington, Seattle, United States
    Competing interests
    The authors declare that no competing interests exist.
  10. Matthew D Campbell

    Radiology, University of Washington, Seattle, United States
    Competing interests
    The authors declare that no competing interests exist.
  11. Tong Zhang

    Biological Sciences Division, Pacific Northwest National Laboratory, Richland, United States
    Competing interests
    The authors declare that no competing interests exist.
  12. Matthew J Gaffrey

    Biological Sciences Division, Pacific Northwest National Laboratory, Richland, United States
    Competing interests
    The authors declare that no competing interests exist.
  13. Gennifer Merrihew

    Genome Science, University of Washington, Seattle, United States
    Competing interests
    The authors declare that no competing interests exist.
  14. Lu Wang

    Environmental and Occupational Health Sciences, University of Washington, Seattle, United States
    Competing interests
    The authors declare that no competing interests exist.
  15. Yongping Yue

    Molecular Microbiology and Immunology, University of Missouri, Columbia, United States
    Competing interests
    The authors declare that no competing interests exist.
  16. Dongsheng Duan

    Department of Molecular Microbiology and Immunology, University of Missouri, Columbia, United States
    Competing interests
    The authors declare that no competing interests exist.
  17. Henk L Granzier

    Cellular and Molecular Medicine, University of Arizona, Tucson, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-9516-407X
  18. Hazel H Szeto

    Social Profit Network, Menlo Park, United States
    Competing interests
    The authors declare that no competing interests exist.
  19. Wei-Jun Qian

    Biological Sciences Division, Pacific Northwest National Laboratory, Richland, United States
    Competing interests
    The authors declare that no competing interests exist.
  20. David Marcinek

    Radiology, University of Washington, Seattle, United States
    Competing interests
    The authors declare that no competing interests exist.
  21. Michael J MacCoss

    Department of Genome Sciences, University of Washington, Seattle, United States
    Competing interests
    The authors declare that no competing interests exist.
  22. Peter Rabinovitch

    Pathology, University of Washington, Seattle, United States
    For correspondence
    petersr@uw.edu
    Competing interests
    The authors declare that no competing interests exist.

Funding

Glenn Foundation for Medical Research (Glenn/AFAR Postdoctoral Fellowship Program for Translational Research on Aging)

  • Ying Ann Chiao

National Institute on Aging (5T32AG000057 Training Grant)

  • Ying Ann Chiao

National Institute on Aging (K99/R00 AG051735)

  • Ying Ann Chiao

National Institute on Aging (P01 AG001751)

  • Peter Rabinovitch

National Institute on Aging (P30 AG013280)

  • Peter Rabinovitch

Glenn Foundation for Medical Research (Glenn/AFAR Postdoctoral Fellowship Program for Translational Research on Aging)

  • Huiliang Zhang

American Heart Association (CDA 19CDA34660311)

  • Huiliang Zhang

National Heart, Lung, and Blood Institute (R35HL144998)

  • Henk L Granzier

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: All mice were handled according to the guidelines of the Institutional Animal Care and Use Committee of the University of Washington and approved IACUC Protocol # 2174-23 . Mice were housed at 20ºC in an AAALAC accredited facility under Institutional Animal Care Committee supervision.

Copyright

© 2020, Chiao et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 4,285
    views
  • 629
    downloads
  • 92
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Ying Ann Chiao
  2. Huiliang Zhang
  3. Mariya Sweetwyne
  4. Jeremy Whitson
  5. Ying Sonia Ting
  6. Nathan Basisty
  7. Lindsay K Pino
  8. Ellen Quarles
  9. Ngoc-Han Nguyen
  10. Matthew D Campbell
  11. Tong Zhang
  12. Matthew J Gaffrey
  13. Gennifer Merrihew
  14. Lu Wang
  15. Yongping Yue
  16. Dongsheng Duan
  17. Henk L Granzier
  18. Hazel H Szeto
  19. Wei-Jun Qian
  20. David Marcinek
  21. Michael J MacCoss
  22. Peter Rabinovitch
(2020)
Late-life restoration of mitochondrial function reverses cardiac dysfunction in old mice
eLife 9:e55513.
https://doi.org/10.7554/eLife.55513

Share this article

https://doi.org/10.7554/eLife.55513

Further reading

    1. Medicine
    2. Neuroscience
    Tomohiro Umeda, Ayumi Sakai ... Takami Tomiyama
    Research Article

    Neurodegenerative diseases are age-related disorders characterized by the cerebral accumulation of amyloidogenic proteins, and cellular senescence underlies their pathogenesis. Thus, it is necessary for preventing these diseases to remove toxic proteins, repair damaged neurons, and suppress cellular senescence. As a source for such prophylactic agents, we selected zizyphi spinosi semen (ZSS), a medicinal herb used in traditional Chinese medicine. Oral administration of ZSS hot water extract ameliorated Aβ and tau pathology and cognitive impairment in mouse models of Alzheimer’s disease and frontotemporal dementia. Non-extracted ZSS simple crush powder showed stronger effects than the extract and improved α-synuclein pathology and cognitive/motor function in Parkinson’s disease model mice. Furthermore, when administered to normal aged mice, the ZSS powder suppressed cellular senescence, reduced DNA oxidation, promoted brain-derived neurotrophic factor expression and neurogenesis, and enhanced cognition to levels similar to those in young mice. The quantity of known active ingredients of ZSS, jujuboside A, jujuboside B, and spinosin was not proportional to the nootropic activity of ZSS. These results suggest that ZSS simple crush powder is a promising dietary material for the prevention of neurodegenerative diseases and brain aging.

    1. Medicine
    2. Neuroscience
    Joanna Kosinska, Julian C Assmann ... Markus Schwaninger
    Research Article

    Monomethyl fumarate (MMF) and its prodrug dimethyl fumarate (DMF) are currently the most widely used agents for the treatment of multiple sclerosis (MS). However, not all patients benefit from DMF. We hypothesized that the variable response of patients may be due to their diet. In support of this hypothesis, mice subjected to experimental autoimmune encephalomyelitis (EAE), a model of MS, did not benefit from DMF treatment when fed a lauric acid-rich (LA) diet. Mice on normal chow (NC) diet, in contrast, and even more so mice on high-fiber (HFb) diet showed the expected protective DMF effect. DMF lacked efficacy in the LA diet-fed group despite similar resorption and preserved effects on plasma lipids. When mice were fed the permissive HFb diet, the protective effect of DMF treatment depended on hydroxycarboxylic receptor 2 (HCAR2) which is highly expressed in neutrophil granulocytes. Indeed, deletion of Hcar2 in neutrophils abrogated DMF protective effects in EAE. Diet had a profound effect on the transcriptional profile of neutrophils and modulated their response to MMF. In summary, DMF required HCAR2 on neutrophils as well as permissive dietary effects for its therapeutic action. Translating the dietary intervention into the clinic may improve MS therapy.